Your browser doesn't support javascript.
loading
Comparisons of the rate of acute myocardial infarction between COVID-19 patients and individuals received COVID-19 vaccines: a population-based study
Oscar Hou In Chou; Cheuk To Chung; Danish Iltaf Satti; Jiandong Zhou; Teddy Tai Loy Lee; Abraham Ka Chung Wai; Tong Liu; Sharen Lee; Vassilios S Vassiliou; Bernard Man Yung Cheung; Gary Tse.
Affiliation
  • Oscar Hou In Chou; Cardiovascular Analytics Group
  • Cheuk To Chung; Cardiovascular Analytics Group
  • Danish Iltaf Satti; Cardiovascular Analytics Group, Hong Kong, China-UK Collaboration
  • Jiandong Zhou; University of Oxford
  • Teddy Tai Loy Lee; Cardiovascular Analytics Group
  • Abraham Ka Chung Wai; HKU
  • Tong Liu; Tianjin Medical University
  • Sharen Lee; Cardiovascular Analytics Group
  • Vassilios S Vassiliou; University of East Anglia
  • Bernard Man Yung Cheung; HKU
  • Gary Tse; Tianjin Medical University
Preprint in English | medRxiv | ID: ppmedrxiv-22277985
ABSTRACT
BackgroundBoth Coronavirus Disease-2019 (COVID-19) infection and COVID-19 vaccination have been associated with the development of acute myocardial infarction (AMI). This study compared the rates of AMI after COVID-19 infection and among the COVID-19 vaccinated populations in Hong Kong. MethodsThis was a population-based cohort study from Hong Kong, China. Patients with positive real time-polymerase chain reaction (RT-PCR) test for COVID-19 between January 1st, 2020 and June 30th, 2021 were included. The data of the vaccinated and unvaccinated population was obtained from the "Reference Data of Adverse Events in Public Hospitals" published by the local government. The individuals who were vaccinated with COVID-19 vaccination prior the observed period (December 6th, 2021 to January 2nd, 2022) in Hong Kong were also included. The vaccination data of other countries were obtained by searching PubMed using the terms ["COVID-19 vaccine" AND "Myocardial infarction"] from its inception to February 1st, 2022. The main exposures were COVID-19 test positivity or previous COVID-19 vaccination. The primary outcome was the development of AMI within 28 days observed period. ResultsThis study included 11441 COVID-19 patients, of whom 25 suffered from AMI within 28 days of exposure (rate per million 2185; 95% confidence interval [CI] 1481-3224). The rates of AMI were much higher than those who were not vaccinated by the COVID-19 vaccine before December 6th, 2021 (rate per million 162; 95% CI 147-162) with a rate ratio of 13.5 (95% CI 9.01-20.2). Meanwhile, the rate of AMI was lower amongst the vaccinated population (rate per million 47; 95% CI 41.3-53.5) than COVID-19 infection with a rate ratio of 0.02 (0.01, 0.03). Regarding post-vaccination AMI, COVID-19 infection was associated with a significantly higher rate of AMI than post-COVID-19 vaccination AMI in other countries. ConclusionsCOVID-19 infection was associated with a higher rate of AMI than the vaccinated general population, and those immediately after COVID-19 vaccination.
License
cc_by
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Observational study / Prognostic study / Review Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Cohort_studies / Observational study / Prognostic study / Review Language: English Year: 2022 Document type: Preprint
...